These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31505197)

  • 1. The evolutionarily conserved C-terminal peptide of troponin I is an independently configured regulatory structure to function as a myofilament Ca
    Wong S; Feng HZ; Jin JP
    J Mol Cell Cardiol; 2019 Nov; 136():42-52. PubMed ID: 31505197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The muscle-relaxing C-terminal peptide from troponin I populates a nascent helix, facilitating binding to tropomyosin with a potent therapeutic effect.
    Hornos F; Feng HZ; Rizzuti B; Palomino-Schätzlein M; Wieczorek D; Neira JL; Jin JP
    J Biol Chem; 2021; 296():100228. PubMed ID: 33814345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium-regulated conformational change in the C-terminal end segment of troponin I and its binding to tropomyosin.
    Zhang Z; Akhter S; Mottl S; Jin JP
    FEBS J; 2011 Sep; 278(18):3348-59. PubMed ID: 21777381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restrictive cardiomyopathy mutations demonstrate functions of the C-terminal end-segment of troponin I.
    Akhter S; Bueltmann K; Huang X; Jin JP
    Arch Biochem Biophys; 2014 Jun; 552-553():3-10. PubMed ID: 24326031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The highly conserved COOH terminus of troponin I forms a Ca2+-modulated allosteric domain in the troponin complex.
    Jin JP; Yang FW; Yu ZB; Ruse CI; Bond M; Chen A
    Biochemistry; 2001 Feb; 40(8):2623-31. PubMed ID: 11327886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and functional studies on Troponin I and Troponin C interactions.
    Ngai SM; Pearlstone JR; Farah CS; Reinach FC; Smillie LB; Hodges RS
    J Cell Biochem; 2001 Jun 26-Jul 25; 83(1):33-46. PubMed ID: 11500952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-terminal troponin-I residues trap tropomyosin in the muscle thin filament blocked-state.
    Lehman W; Pavadai E; Rynkiewicz MJ
    Biochem Biophys Res Commun; 2021 Apr; 551():27-32. PubMed ID: 33714756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative studies on the functional roles of N- and C-terminal regions of molluskan and vertebrate troponin-I.
    Tanaka H; Takeya Y; Doi T; Yumoto F; Tanokura M; Ohtsuki I; Nishita K; Ojima T
    FEBS J; 2005 Sep; 272(17):4475-86. PubMed ID: 16128816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of deletion mutants of troponins I and T: COOH-terminal truncation of troponin T abolishes troponin I binding and reduces Ca2+ sensitivity of the reconstituted regulatory system.
    Jha PK; Leavis PC; Sarkar S
    Biochemistry; 1996 Dec; 35(51):16573-80. PubMed ID: 8987992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mutation in the N-terminus of troponin I that is associated with hypertrophic cardiomyopathy affects the Ca(2+)-sensitivity, phosphorylation kinetics and proteolytic susceptibility of troponin.
    Gomes AV; Harada K; Potter JD
    J Mol Cell Cardiol; 2005 Nov; 39(5):754-65. PubMed ID: 16005017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins.
    Alves ML; Dias FAL; Gaffin RD; Simon JN; Montminy EM; Biesiadecki BJ; Hinken AC; Warren CM; Utter MS; Davis RT; Sakthivel S; Robbins J; Wieczorek DF; Solaro RJ; Wolska BM
    Circ Cardiovasc Genet; 2014 Apr; 7(2):132-143. PubMed ID: 24585742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ca(2+)-regulatory function of the inhibitory peptide region of cardiac troponin I is aided by the C-terminus of cardiac troponin T: Effects of familial hypertrophic cardiomyopathy mutations cTnI R145G and cTnT R278C, alone and in combination, on filament sliding.
    Brunet NM; Chase PB; Mihajlović G; Schoffstall B
    Arch Biochem Biophys; 2014 Jun; 552-553():11-20. PubMed ID: 24418317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lys184 deletion in troponin I impairs relaxation kinetics and induces hypercontractility in murine cardiac myofibrils.
    Iorga B; Blaudeck N; Solzin J; Neulen A; Stehle I; Lopez Davila AJ; Pfitzer G; Stehle R
    Cardiovasc Res; 2008 Mar; 77(4):676-86. PubMed ID: 18096573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the biologically important interaction between troponin C and the N-terminal region of troponin I.
    Ngai SM; Pearlstone JR; Smillie LB; Hodges RS
    J Cell Biochem; 2001 Jun 26-Jul 25; 83(1):99-110. PubMed ID: 11500958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Energetics of the induced structural change in a Ca2+ regulatory protein: Ca2+ and troponin I peptide binding to the E41A mutant of the N-domain of skeletal troponin C.
    McKay RT; Saltibus LF; Li MX; Sykes BD
    Biochemistry; 2000 Oct; 39(41):12731-8. PubMed ID: 11027154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Relaxation Properties of Myofibrils Are Compromised by Amino Acids that Stabilize α-Tropomyosin.
    Scellini B; Piroddi N; Matyushenko AM; Levitsky DI; Poggesi C; Lehrer SS; Tesi C
    Biophys J; 2017 Jan; 112(2):376-387. PubMed ID: 28122223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of structural C and regulatory N domains of troponin C with repeated sequence motifs in troponin I.
    Pearlstone JR; Sykes BD; Smillie LB
    Biochemistry; 1997 Jun; 36(24):7601-6. PubMed ID: 9200712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of a troponin I (R145G) mutation associated with familial hypertrophic cardiomyopathy.
    Lang R; Gomes AV; Zhao J; Housmans PR; Miller T; Potter JD
    J Biol Chem; 2002 Apr; 277(14):11670-8. PubMed ID: 11801593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the mutation R145G in human cardiac troponin I on the kinetics of the contraction-relaxation cycle in isolated cardiac myofibrils.
    Kruger M; Zittrich S; Redwood C; Blaudeck N; James J; Robbins J; Pfitzer G; Stehle R
    J Physiol; 2005 Apr; 564(Pt 2):347-57. PubMed ID: 15718266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dilated cardiomyopathy-causing mutation ACTC E361G in cardiac muscle myofibrils specifically abolishes modulation of Ca(2+) regulation by phosphorylation of troponin I.
    Vikhorev PG; Song W; Wilkinson R; Copeland O; Messer AE; Ferenczi MA; Marston SB
    Biophys J; 2014 Nov; 107(10):2369-80. PubMed ID: 25418306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.